{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T04:01:13Z","timestamp":1746936073233,"version":"3.40.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00520-025-09427-4","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:27:06Z","timestamp":1744097226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone dose-dependently attenuates docetaxel-induced peripheral neuropathy in breast cancer treatment"],"prefix":"10.1007","volume":"33","author":[{"given":"Ryota","family":"Kanno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Takekuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Oshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"9427_CR1","doi-asserted-by":"publisher","first-page":"CD004421","DOI":"10.1002\/14651858.CD004421.pub3","volume":"9","author":"ML Willson","year":"2019","unstructured":"Willson ML, Burke L, Ferguson T, Ghersi D, Nowak AK, Wilcken N (2019) Taxanes for adjuvant treatment of early breast cancer review. Cochrane Database Syst Rev 9:CD004421. https:\/\/doi.org\/10.1002\/14651858.CD004421.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"9427_CR2","doi-asserted-by":"publisher","first-page":"CD003366","DOI":"10.1002\/14651858.CD003366.pub3","volume":"2015","author":"D Ghersi","year":"2015","unstructured":"Ghersi D, Willson ML, Chan MMK, Simes J, Donoghue E, Wilcken N (2015) Taxane-containing regimens for metastatic breast cancer review. Cochrane Database Syst Rev 2015:CD003366. https:\/\/doi.org\/10.1002\/14651858.CD003366.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"9427_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejca.2014.11.024","volume":"51","author":"L Eckhoff","year":"2015","unstructured":"Eckhoff L, Knoop AS, Jensen MB, Ewertz M (2015) Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer 51:292\u2013300. https:\/\/doi.org\/10.1016\/j.ejca.2014.11.024","journal-title":"Eur J Cancer"},{"key":"9427_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10549-013-2728-2","volume":"142","author":"L Eckhoff","year":"2013","unstructured":"Eckhoff L, Knoop AS, Jensen MB, Ejlertsen B, Ewertz M (2013) Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer. Breast Cancer Res Treat 142:109\u2013118. https:\/\/doi.org\/10.1007\/s10549-013-2728-2","journal-title":"Breast Cancer Res Treat"},{"key":"9427_CR5","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1200\/JCO.2017.72.3494","volume":"35","author":"B Ejlertsen","year":"2017","unstructured":"Ejlertsen B, Tuxen MK, Jakobsen EH, Jensen MB, Knoop AS, H\u00f8jris I et al (2017) Adjuvant cyclophosphamide and docetaxel with or without epirubicin for early TOP2A-nomal breast cancer: DBCG 07-READ, an open- label, phase III, randomized trial. J Clin Oncol 35:2640\u20132646. https:\/\/doi.org\/10.1200\/JCO.2017.72.3494","journal-title":"J Clin Oncol"},{"key":"9427_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","volume":"291","author":"AS Jaggi","year":"2012","unstructured":"Jaggi AS, Singh N (2012) Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology 291:1\u20139. https:\/\/doi.org\/10.1016\/j.tox.2011.10.019","journal-title":"Toxicology"},{"key":"9427_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clbc.2011.03.006","volume":"11","author":"K Carlson","year":"2011","unstructured":"Carlson K, Ocean AJ (2011) Peripheral neuropathy with microtubule targeting agents: occurrence and management approach. Clin Breast Cancer 11:73\u201381. https:\/\/doi.org\/10.1016\/j.clbc.2011.03.006","journal-title":"Clin Breast Cancer"},{"key":"9427_CR8","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1002\/cam4.3129","volume":"9","author":"K Bennedsgaard","year":"2020","unstructured":"Bennedsgaard K, Ventzel L, Themistocleous AC, Bennett DL, Jensen AB, Jensen AR et al (2020) Long-term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy. Cancer Med 9:5114\u20135123. https:\/\/doi.org\/10.1002\/cam4.3129","journal-title":"Cancer Med"},{"key":"9427_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","volume":"159","author":"T Bao","year":"2016","unstructured":"Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159:327\u2013333. https:\/\/doi.org\/10.1007\/s10549-016-3939-0","journal-title":"Breast Cancer Res Treat"},{"key":"9427_CR10","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00520-014-2255-7","volume":"22","author":"F Mols","year":"2014","unstructured":"Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L (2014) Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer 22:2261\u20132269. https:\/\/doi.org\/10.1007\/s00520-014-2255-7","journal-title":"Support Care Cancer"},{"key":"9427_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00520-019-04808-y","volume":"28","author":"Y Saito","year":"2020","unstructured":"Saito Y, Kobayashi M, Yamada T, Sakakibara-Konishi J, Shinagawa N, Kinoshita I et al (2020) Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acute pain syndrome. Support Care Cancer 28:221\u2013227. https:\/\/doi.org\/10.1007\/s00520-019-04808-y","journal-title":"Support Care Cancer"},{"key":"9427_CR12","doi-asserted-by":"publisher","first-page":"8059","DOI":"10.1007\/s00520-021-06342-2","volume":"29","author":"Y Saito","year":"2021","unstructured":"Saito Y, Takekuma Y, Kobayashi M, Sakamoto T, Yamashita H, Sugawara M (2021) Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis. Support Care Cancer 29:8059\u20138067. https:\/\/doi.org\/10.1007\/s00520-021-06342-2","journal-title":"Support Care Cancer"},{"key":"9427_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00520-017-3836-z","volume":"26","author":"N Chiu","year":"2018","unstructured":"Chiu N, Zhang L, Dent R, Giotis A, van Draanen J, Gallo-Hershberg D et al (2018) A prospective study of docetaxel-associated pain syndrome. Support Care Cancer 26:203\u2013211. https:\/\/doi.org\/10.1007\/s00520-017-3836-z","journal-title":"Support Care Cancer"},{"key":"9427_CR14","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1200\/JCO.2010.33.0308","volume":"29","author":"CL Loprinzi","year":"2011","unstructured":"Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN et al (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29:1472\u20131478. https:\/\/doi.org\/10.1200\/JCO.2010.33.0308","journal-title":"J Clin Oncol"},{"key":"9427_CR15","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1002\/cncr.27489","volume":"118","author":"BN Reeves","year":"2012","unstructured":"Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A et al (2012) Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. Cancer 118:5171\u20135178. https:\/\/doi.org\/10.1002\/cncr.27489","journal-title":"Cancer"},{"key":"9427_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12282-011-0297-y","volume":"19","author":"M Hosonaga","year":"2012","unstructured":"Hosonaga M, Ito Y, Tokudome N, Takahashi S, Iwase T, Hatake K (2012) A lower dose of docetaxel at 60 mg\/m2 could be continued longer for controlling peripheral edema in patients with metastatic breast cancer. Breast Cancer 19:329\u2013334. https:\/\/doi.org\/10.1007\/s12282-011-0297-y","journal-title":"Breast Cancer"},{"key":"9427_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000336480","volume":"82","author":"S Ohsumi","year":"2012","unstructured":"Ohsumi S, Shimozuma K, Ohashi Y, Takeuchi A, Suemasu K, Kuranami M et al (2012) Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: the national surgical adjuvant study of breast cancer 02. Oncology 82:131\u2013138. https:\/\/doi.org\/10.1159\/000336480","journal-title":"Oncology"},{"key":"9427_CR18","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1200\/JCO.2005.02.027","volume":"23","author":"SE Jones","year":"2005","unstructured":"Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E et al (2005) Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 23:5542\u20135551. https:\/\/doi.org\/10.1200\/JCO.2005.02.027","journal-title":"J Clin Oncol"},{"key":"9427_CR19","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1038\/s41598-023-36264-4","volume":"13","author":"Y Saito","year":"2023","unstructured":"Saito Y, Kanno R, Takekuma Y, Takeshita T, Oshino T, Sugawara M (2023) High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment. Sci Rep 13:9247. https:\/\/doi.org\/10.1038\/s41598-023-36264-4","journal-title":"Sci Rep"},{"key":"9427_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00520-023-07852-x","volume":"31","author":"Y Saito","year":"2023","unstructured":"Saito Y, Takekuma Y, Takeshita T, Oshino T, Sugawara M (2023) Dexamethasone dose-dependently prevents taxane-associated acute pain syndrome in breast cancer treatment. Support Care Cancer 31:372. https:\/\/doi.org\/10.1007\/s00520-023-07852-x","journal-title":"Support Care Cancer"},{"key":"9427_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s10147-024-02535-x","volume":"29","author":"H Iihara","year":"2024","unstructured":"Iihara H, Abe M, Wada M, Iino K, Akechi T, Imamura CK et al (2024) 2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis. Int J Clin Oncol 29:873\u2013888. https:\/\/doi.org\/10.1007\/s10147-024-02535-x","journal-title":"Int J Clin Oncol"},{"issue":"Supplement 3","key":"9427_CR22","first-page":"1","volume":"20","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20(Supplement 3):1\u201315","journal-title":"Semin Oncol"},{"key":"9427_CR23","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1111\/tbj.14123","volume":"26","author":"L Pabst","year":"2020","unstructured":"Pabst L, Velten M, Fischbach C, Kalish M, Pflumio C, Pivot X et al (2020) Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer. Breast J 26:2376\u20132382. https:\/\/doi.org\/10.1111\/tbj.14123","journal-title":"Breast J"},{"key":"9427_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/toxics9100229","volume":"9","author":"I Klein","year":"2021","unstructured":"Klein I, Lehmann HC (2021) Pathomechanisms of paclitaxel-induced peripheral neuropathy. Toxics 9:229. https:\/\/doi.org\/10.3390\/toxics9100229","journal-title":"Toxics"},{"key":"9427_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1124\/jpet.110.175976","volume":"337","author":"Y Tatsushima","year":"2011","unstructured":"Tatsushima Y, Egashira N, Kawashiri T, Mihara Y, Yano T, Mishima K et al (2011) Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin. J Pharmacol Exp Ther 337:226\u2013235. https:\/\/doi.org\/10.1124\/jpet.110.175976","journal-title":"J Pharmacol Exp Ther"},{"key":"9427_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/glia.23557","volume":"67","author":"X Yan","year":"2019","unstructured":"Yan X, Li F, Maixner DW, Yadav R, Gao M, Ali MW et al (2019) Interleukin-1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel-associated acute pain syndrome. Glia 67:482\u2013497. https:\/\/doi.org\/10.1002\/glia.23557","journal-title":"Glia"},{"key":"9427_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ejp.1660","volume":"25","author":"GC Zanata","year":"2021","unstructured":"Zanata GC, Pinto LG, da Silva NR, Lopes AHP, de Oliveira FFB, Schivo IRS et al (2021) Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel-associated acute pain syndrome in mice. Eur J Pain 25:189\u2013198. https:\/\/doi.org\/10.1002\/ejp.1660","journal-title":"Eur J Pain"},{"key":"9427_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00520-019-04845-7","volume":"28","author":"R Asthana","year":"2020","unstructured":"Asthana R, Zhang L, Wan BA, Gallo-Hershberg D, Giotis A, Pasetka M et al (2020) Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients\u2014a prospective clinical study. Support Care Cancer 28:589\u2013598. https:\/\/doi.org\/10.1007\/s00520-019-04845-7","journal-title":"Support Care Cancer"},{"key":"9427_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/rheumatology\/keu315","volume":"54","author":"R Mousavizadeh","year":"2015","unstructured":"Mousavizadeh R, Backman L, McCormack RG, Scott A (2015) Dexamethasone decreases substance P expression in human tendon cells: an in vitro study. Rheumatology (Oxford) 54:318\u2013323. https:\/\/doi.org\/10.1093\/rheumatology\/keu315","journal-title":"Rheumatology (Oxford)"},{"key":"9427_CR30","first-page":"90","volume":"71","author":"F Beaudry","year":"2007","unstructured":"Beaudry F, Girard C, Vachon P (2007) Early dexamethasone treatment after implantation of a sciatic-nerve cuff decreases the concentration of substance P in the lumbar spinal cord of rats with neuropathic pain. Can J Vet Res 71:90\u201397","journal-title":"Can J Vet Res"},{"key":"9427_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1172\/JCI113301","volume":"81","author":"JA Kern","year":"1988","unstructured":"Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC (1988) Dexamethasone inhibition of interleukin 1beta production by human monocytes. Posttranscriptional Mech J Clin Invest 81:237\u2013244. https:\/\/doi.org\/10.1172\/JCI113301","journal-title":"Posttranscriptional Mech J Clin Invest"},{"key":"9427_CR32","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1016\/s0014-2999(98)00478-6","volume":"354","author":"F Schmidlin","year":"1998","unstructured":"Schmidlin F, Scherrer D, Landry Y, Gies JP (1998) Glucocorticoids inhibit the bradykinin B2 receptor increase induced by interleukin-1\u03b2 in human bronchial smooth muscle cells. Eur J Pharmacol 354:R7\u2013R8. https:\/\/doi.org\/10.1016\/s0014-2999(98)00478-6","journal-title":"Eur J Pharmacol"},{"key":"9427_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2222.2005.02207.x","volume":"35","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Adner M, Cardell LO (2005) Glucocorticoids suppress transcriptional up-regulation of bradykinin receptors in a murine in vitro model of chronic airway inflammation. Clin Exp Allergy 35:531\u2013538. https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02207.x","journal-title":"Clin Exp Allergy"},{"key":"9427_CR34","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1200\/JCO.2016.71.3552","volume":"35","author":"KM Winters-Stone","year":"2017","unstructured":"Winters-Stone KM, Horak F, Jacobs PG, Trubowitz P, Dieckmann NF, Stoyles S et al (2017) Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 35:2604\u20132612. https:\/\/doi.org\/10.1200\/JCO.2016.71.3552","journal-title":"J Clin Oncol"},{"key":"9427_CR35","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/cas.12525","volume":"105","author":"Y Ito","year":"2014","unstructured":"Ito Y, Miyashiro I, Ito H, Hosono S, Chihara D, Nakata-Yamada K et al (2014) Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci 105:1480\u20131486. https:\/\/doi.org\/10.1111\/cas.12525","journal-title":"Cancer Sci"},{"key":"9427_CR36","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS et al (2015) Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385:977\u20131010. https:\/\/doi.org\/10.1016\/S0140-6736(14)62038-9","journal-title":"Lancet"},{"key":"9427_CR37","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EML Smith","year":"2013","unstructured":"Smith EML, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309:1359\u20131367. https:\/\/doi.org\/10.1001\/jama.2013.2813","journal-title":"JAMA"},{"key":"9427_CR38","doi-asserted-by":"crossref","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 38:3325\u20133348. https:\/\/pubmed.ncbi.nlm.nih.gov\/32663120\/. Accessed 08-05-2024","DOI":"10.1200\/JCO.20.01399"},{"key":"9427_CR39","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0140-6736(22)01472-6","volume":"400","author":"S Tesfaye","year":"2022","unstructured":"Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S et al (2022) Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet 400:680\u2013690. https:\/\/doi.org\/10.1016\/S0140-6736(22)01472-6","journal-title":"Lancet"},{"key":"9427_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/jrms.JRMS_1068_17","volume":"23","author":"A Razieh","year":"2018","unstructured":"Razieh A, Ghasem J, Narjes H, Abbas A, Samaneh B, Nasim T et al (2018) The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial. J Res Med Sci 23:52. https:\/\/doi.org\/10.4103\/jrms.JRMS_1068_17","journal-title":"J Res Med Sci"},{"key":"9427_CR41","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1186\/s12885-023-11560-4","volume":"23","author":"S Misawa","year":"2023","unstructured":"Misawa S, Denda T, Kodama S, Suzuki T, Naito Y, Kogawa T et al (2023) Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study). BMC Cancer 23:1098. https:\/\/doi.org\/10.1186\/s12885-023-11560-4","journal-title":"BMC Cancer"},{"key":"9427_CR42","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00520-017-4028-6","volume":"26","author":"A Kuriyama","year":"2018","unstructured":"Kuriyama A, Endo K (2018) Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Support Care Cancer 26:1051\u20131059. https:\/\/doi.org\/10.1007\/s00520-017-4028-6","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09427-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09427-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09427-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:30:23Z","timestamp":1746851423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09427-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["9427"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09427-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures performed in studies involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"360"}}